retatrutide trial results news Retatrutide, a new weight loss drug not available on the market yet, is showing promising in trials. @DrLaPook explains it’s doing much more than what current medications can ESC 2024: Retatrutide improves lipid

This makes the GCGR component particularly relevant for research into non-alcoholic fatty liver disease (NAFLD) models and energy balance studies

Researchers also observed a potential increase in epithelialization, a process critical for regenerating the skins outer layer, under these experimental conditions

The peptide is typically sold in two chemical forms used in compounding and research: BPC-157 free base (also called the pure peptide) and BPC-157 acetate , a trifluoroacetate-free salt form

Metabolic Healing GLP-1 agonists not only facilitate weight loss but also help heal metabolic dysfunction

However, based on anecdotal evidence and limited research, there are a few safety considerations to be aware of